Navigation Links
VIA Pharmaceuticals to Present Poster at AHA Arteriosclerosis, Thrombosis and Vascular Biology Conference 2009
Date:3/31/2009

Data from ACS Phase 2 MDCT Sub-study to be Released Concurrent with AHA Presentation

SAN FRANCISCO, March 31 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that an abstract on the Company's Phase 2 clinical trial of VIA-2291 has been accepted for a poster presentation at the American Heart Association Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009, taking place April 29 - May 1, 2009 in Washington, D.C. The presentation will summarize results of a sub-study of patients from the Company's acute coronary syndrome (ACS) trial who received serial 64 slice multidetector computed tomography (MDCT) scans before and after six months of treatment with VIA-2291.

Given AHA's embargo policy, the company will announce the data from the MDCT sub-study concurrent with the presentation.

    The poster presentation details are as follows:
          Date / Time:   Friday, May 1, 2009 8:00 a.m. - 10:00 a.m. EDT
          Location:      Omni Shoreham Hotel, Washington, DC
          Presentation:  P555
          Title:         Evaluation of Coronary Artery Atherosclerotic Plaque
                         by Serial 64-Slice Multidetector Computed Tomography
                         in Patients with Recent Acute Coronary Syndrome
                         Treated for 6 Months with 5-Lipoxygenase Inhibitor
                         VIA-2291
          Authors:       Josephine Pressacco, Montreal Heart Institute;
                         Rebecca Taub, VIA Pharmaceuticals, Inc.; Marieve
                         Cossette, Anna Nozza, Janie Paquin, Simon Kouz, Reda
                         Ibrahim, Jean Gregoire, Phillippe L'Allier, Montreal
     
'/>"/>
SOURCE  VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24...Nasdaq: DCGN ) today announced the approval of all... Court for the District of Delaware,(the "Bankrupt...ition for,relief under Chapter 11 of the United St..., The orders issued by the Bankruptcy Court...
(Date:11/24/2009)..., SEATTLE, Nov. 24 Blue Marble Ene... Odessa Public Development Authority (OPDA) were r...ommunity Economic Revitalization Board (CERB) in a...,s first specialty biochemical biorefinery in Linc...ificantly speed the development of our biorefinery...
(Date:11/24/2009)..., DUBLIN, November 24 /PRNewswire-FirstCall/ ...al specialty biopharmaceutical company, today,anno...Medicines Agency for,velaglucerase alfa, the compa... the treatment of Type 1 Gaucher disease. This is ...alfa that has been submitted, with previous,submis...
(Date:11/24/2009)... Program Connects Customers with Pa...llected with DNA Genotek Products , ... DNA Genotek , a leading provider of products for...reparation, today announced its new global partner...nts for DNA Genotek,s partner community and is des...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...Jones II named Vice President and General Manager ...lion prescriptions a week, FRANKLIN LAKES, N.J., ...), one of the nation,s leading pharmacy benefit,ma... Whitestown, Indiana,will be the home of world,s l...g a nearly year-long search that spanned 48 states...
...Mass., Dec. 18 ActivBiotics, Inc. today,announced...r its clinical,trial of Rifalazil failed in periph...ling all or substantially all of its assets on an ...t of Creditors, process. The,Assignee of the asset...s,below). The bidding for the assets, which may be...
...Mich., Dec. 18 Stryker Corporation,(NYSE: SYK ) ...ednesday,January 23, 2008 at 4:30 p.m., Eastern Ti... the quarter and year ended December 31, 2007 and,...or the quarter and year,ended December 31, 2007 wi... MacMillan, President and Chief Executive Officer,...
Other Biology Technology:Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 2Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 3Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 4Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the World's Largest, Most-Advanced Automated Pharmacy 5ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates 2ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates 3Stryker to Host Conference Call on January 23, 2008 2
(Date:11/24/2009)..., 2009) -- The Wildlife Conservation Society (WCS)...remaining population of Siberian tigers has likely...poaching and habitat loss. , WCS say... what needs to be done to protect remaining popula... The report was released by the Siberian Tiger Mon...
(Date:11/24/2009)...h . , The presence of increased body fat, an...es in the blood, hinders the loss and maintenance ...the University of Navarra conducted by Estbaliz Go...cy. , The project, entitled "A nutrigenetic and ...ody weight and inflammation," examines how the ind...
(Date:11/23/2009)...me of day matters to forest trees dealing with dro...rch team led by Professor Malcolm Campbell, Univer...esearch and colleagues in the department of cell a... Capitalizing on their previous work to decode the...ined how poplar trees use their 45,000 genes to re...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 1Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 2Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 58840 3Child burn injuries down significantly 58836 1Child burn injuries down significantly 58836 2Child burn injuries down significantly 58836 3AMERIGROUP Foundation Supports Groundbreaking on Grommet Island Park for People With Disabilities 14342 1AMERIGROUP Foundation Supports Groundbreaking on Grommet Island Park for People With Disabilities 14342 2
...ters in 11 states are the latest members of the Na...ional Science Award (CTSA) consortium. Creating a ...ross the nation, the consortium is working to redu... become treatments for patients and to engage comm...ulfilling the critical need to train the next gene...
... cyclic increase and decrease of jellyfish populat...ne of the U.S.,s most productive fisheries--into v...dy shows that the availability of food for jellyfi...jellyfish population, even while other factors, su...nued growth. , These results indicate that "antic...
...ghout the overlooked depths of Lake Michigan and o...rapidly disappearing. , Until recently, the anima...oreia - was a major food source for commercially i... fish upon which salmon, trout and walleye rely. ,... a quest to explain their population freefall, whi...
Other Biology News:NIH expands national consortium dedicated to transforming clinical and translational research 2NIH expands national consortium dedicated to transforming clinical and translational research 3Scientists discover stinging truths about jellyfish blooms in the Bering Sea 2Scientists discover stinging truths about jellyfish blooms in the Bering Sea 3A Great Lakes mystery: The case of the disappearing species 2A Great Lakes mystery: The case of the disappearing species 3A Great Lakes mystery: The case of the disappearing species 4
Human HGF, Unconjugated from R&D Systems
Anti-alpha1-Antitrypsin Monoclonal Antibody, Unconjugated from CHEMICON
Senescence Colorimetric Assay Kit from BioVision
Mouse LIGHT / TNFSF14, Unconjugated from R&D Systems
Biology Products: